See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Baseball
Natural Disasters
Stock Markets
Social Media
Tariffs
UK Economy
Taxes
Soccer
Donald Trump
Education
Senate
Artificial Intelligence
Published • loading... • Updated

J&J Passes AstraZeneca in Blockbuster Cancer Race

Summary by Bloomberg
Johnson & Johnson has pulled ahead of rival AstraZeneca Plc in a race to dominate the blockbuster market for lung cancer treatment, but data from a forthcoming study could quickly shake up the competition again.

4 Articles

All
Left
1
Center
Right
BloombergBloomberg
Lean Left

J&J Passes AstraZeneca in Blockbuster Cancer Race

Johnson & Johnson has pulled ahead of rival AstraZeneca Plc in a race to dominate the blockbuster market for lung cancer treatment, but data from a forthcoming study could quickly shake up the competition again.

·United States
Read Full Article
PharmaphorumPharmaphorum

J&J throws the gauntlet down to AZ with new survival data

New survival data from MARIPOSA for Johnson & Johnson's Rybrevant/Lazcluze combination in lung cancer could spell trouble for AstraZeneca.

Read Full Article
Endpoints NewsEndpoints News

J&J touts new survival data pitting lung cancer combo against AstraZeneca's rival

Johnson & Johnson released new data suggesting its lung cancer combination Rybrevant and Lazcluze beat AstraZeneca’s Tagrisso on overall survival. In a Phase 3 trial, 56% of patients who took J&J’s combination treatment were alive ...

Read Full Article
stocktitan.netstocktitan.net

Major Breakthrough: AstraZeneca's TAGRISSO Extends Lung Cancer Survival to Nearly 5 Years

New clinical data reveals TAGRISSO's exceptional performance across four trials, with up to 58.8-month survival in EGFR-mutated lung cancer. Full analysis inside.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Tuesday, March 25, 2025.
Sources are mostly out of (0)

Similar News Topics

Johnson & Johnson

Johnson & Johnson

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal